HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Coppertone Lineup Covers Sensitive Skin, Adds Antioxidants

This article was originally published in The Tan Sheet

Executive Summary

Schering-Plough added antioxidants to some products in the 2010 Coppertone sun-care lineup it developed with dermatologists to meet the needs of consumers particularly vulnerable to sun exposure

You may also be interested in...



Schering-Plough’s Coppertone Launches First SPF 70 Continuous Spray Product

Schering-Plough's SPF 70 Coppertone sunscreen product is the industry's first continuous spray sunscreen offering that level of protection, the firm says

PCPC Sees Opportunity For US Cosmetics Modernization After Congressional Mid-Terms

The Personal Care Products Council is pivoting to focus on passing cosmetics modernization legislation after mid-term congressional elections, while still hopeful the language could go through as part of FDA user-fee reauthorization. Karin Ross, executive VP, government affairs at PCPC, discussed the situation at the trade group’s Leadership Summit in Washington.

Estee Lauder Companies Signals Growing Luxury Appetite, Possible M&A On Horizon

ELC’s Guillaume Jesel has been named president of global brands overseeing Tom Ford Beauty and Balmain Beauty, the latter targeted for launch in fall 2024 under a licensing agreement with the French fashion house announced on 26 September. Jesel also will head up luxury business development with a “key role in prospective acquisitions and investment strategy.”

Topics

Latest News
See All
UsernamePublicRestriction

Register

RS134568

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel